Tech Company Financing Transactions

Portola Pharmaceuticals Funding Round

Portola Pharmaceuticals closed a $60 million venture capital round on 7/9/2008. Backers included Adage Capital Management, BBT Fund and D. E. Shaw Group.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds will be used primarily to advance Portola's two lead antithrombotic clinical candidates, betrixaban and PRT060128, which the company is developing as best-in-class compounds to replace existing standards of care. In addition, funds will be used to develop the company's pre-clinical pipeline including its novel Factor Xa inhibitor antidote, which has the potential to expand the use of anticoagulants.

Company Information

Company Status
Acquired or Merged
Mailing Address
270 E. Grand Ave.
South San Francisco, CA 94080
Email Address
Portola Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease. Portola has two drug candidates in clinical development.
Portola Pharmaceuticals LinkedIn Company Profile
Social Media
Portola Pharmaceuticals Company Twitter Account
Company News
Portola Pharmaceuticals News
Portola Pharmaceuticals on Facebook
Portola Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Financial Officer
Mard Dier
  Mard Dier LinkedIn Profile  Mard Dier Twitter Account  Mard Dier News  Mard Dier on Facebook
Chief Medical Officer
John Lawrence?
  John Lawrence? LinkedIn Profile  John Lawrence? Twitter Account  John Lawrence? News  John Lawrence? on Facebook
VP - Bus. Development
Tao Fu
  Tao Fu LinkedIn Profile  Tao Fu Twitter Account  Tao Fu News  Tao Fu on Facebook
VP - Engineering
Glenn Brame
  Glenn Brame LinkedIn Profile  Glenn Brame Twitter Account  Glenn Brame News  Glenn Brame on Facebook
VP - General Counsel
John Moriarty
  John Moriarty LinkedIn Profile  John Moriarty Twitter Account  John Moriarty News  John Moriarty on Facebook
VP - R & D
John Curnutte
  John Curnutte LinkedIn Profile  John Curnutte Twitter Account  John Curnutte News  John Curnutte on Facebook



Browse more venture capital transactions:

Prev: 7/9/2008: Xeround venture capital transaction
Next: 7/9/2008: FeedRoom venture capital transaction


Share this article


About Database of VC Transactions

We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary